All News about Curevac N.V.Via ACCESSWIRE
GSK Buys Full Rights To Investigational Covid-19 And Influenza Vaccines From CureVac For Around $1.5B
July 03, 2024
Via Benzinga
Exposures
COVID-19
CureVac Announces Voting Results of General Meeting
June 24, 2024
Via ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|